Repligen Shares Outstanding 2006-2019 | RGEN

Repligen shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Repligen Annual Shares Outstanding
(Millions of Shares)
2018 45
2017 39
2016 34
2015 34
2014 33
2013 32
2012 31
2011
2011 31
2010 31
2009 31
2008 31
2007 30
2006 31
2005 30
Repligen Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 52
Q2 2019 49
Q1 2019 46
Q4 2018 45
Q3 2018 46
Q2 2018 45
Q1 2018 44
Q4 2017 39
Q3 2017 43
Q2 2017 35
Q1 2017 34
Q4 2016 34
Q3 2016 34
Q2 2016 34
Q1 2016 33
Q4 2015 34
Q3 2015 34
Q2 2015 34
Q1 2015 33
Q4 2014 33
Q3 2014 33
Q2 2014 33
Q1 2014 33
Q4 2013 32
Q3 2013 33
Q2 2013 32
Q1 2013 32
Q4 2012 31
Q3 2012 31
Q2 2012 31
Q1 2012 31
Q4 2011
Q3 2011 31
Q2 2011 31
Q1 2011 31
Q4 2010 31
Q3 2010 31
Q2 2010 31
Q1 2010
Q4 2009 31
Q3 2009 31
Q2 2009 31
Q1 2009
Q4 2008 31
Q3 2008 32
Q2 2008 32
Q1 2008
Q4 2007 31
Q3 2007 31
Q2 2007 31
Q1 2007
Q4 2006 30
Q3 2006 30
Q2 2006 31
Q1 2006
Q4 2005 30
Q3 2005 30
Q2 2005 30
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.603B $0.194B
Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.688B 15.98
CSL (CSLLY) Australia $86.180B 0.00
Gilead Sciences (GILD) United States $83.411B 10.33
Vertex Pharmaceuticals (VRTX) United States $57.362B 58.55
Biogen (BIIB) United States $54.022B 9.27
Illumina (ILMN) United States $47.012B 51.58
Regeneron Pharmaceuticals (REGN) United States $40.442B 17.71
Alexion Pharmaceuticals (ALXN) United States $23.771B 11.74
Incyte (INCY) United States $20.245B 46.99
Seattle Genetics (SGEN) United States $20.080B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.057B 0.00
Genmab (GNMSF) Denmark $14.761B 65.20
BioMarin Pharmaceutical (BMRN) United States $14.384B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.850B 0.00
Galapagos (GLPG) Belgium $11.489B 29.60
Exact Sciences (EXAS) United States $10.855B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.422B 30.72
BeiGene (BGNE) Cayman Islands $9.086B 0.00
Bio-Techne Corp (TECH) United States $8.300B 55.55
Sarepta Therapeutics (SRPT) United States $8.197B 0.00
Amarin (AMRN) Ireland $7.791B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.775B 0.00
Guardant Health (GH) United States $6.910B 0.00
Moderna (MRNA) United States $6.878B 0.00
Medicines (MDCO) United States $6.689B 0.00
Reata Pharmaceuticals (RETA) United States $6.041B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.967B 15.17
ARGENX SE-ADR (ARGX) Netherlands $5.702B 0.00
Exelixis (EXEL) United States $5.211B 14.66
BioNTech SE (BNTX) Germany $5.089B 0.00
Ascendis Pharma (ASND) Denmark $4.626B 0.00
China Biologic Products (CBPO) China $4.590B 25.86
Bluebird Bio (BLUE) United States $4.462B 0.00
Spark Therapeutics (ONCE) United States $4.225B 0.00
Mirati Therapeutics (MRTX) United States $4.133B 0.00
MorphoSys AG (MOR) Germany $4.095B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.921B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.903B 0.00
Blueprint Medicines (BPMC) United States $3.669B 0.00
Adaptive Biotechnologies (ADPT) United States $3.649B 0.00
Immunomedics (IMMU) United States $3.577B 0.00
Alkermes (ALKS) Ireland $3.253B 0.00
Genmab (GMAB) Denmark $3.105B 6.40
MyoKardia (MYOK) United States $3.103B 0.00
UniQure (QURE) Netherlands $2.817B 0.00
Halozyme Therapeutics (HALO) United States $2.793B 0.00
NeoGenomics (NEO) United States $2.722B 144.83
Emergent Biosolutions (EBS) United States $2.714B 26.96
Acceleron Pharma (XLRN) United States $2.584B 0.00
Amicus Therapeutics (FOLD) United States $2.553B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.472B 0.00
Zai Lab (ZLAB) China $2.392B 0.00
Arena Pharmaceuticals (ARNA) United States $2.330B 5.42
RA PHARMCTL INC (RARX) United States $2.208B 0.00
Insmed (INSM) United States $2.016B 0.00
Myriad Genetics (MYGN) United States $1.910B 28.21
Ligand Pharmaceuticals (LGND) United States $1.843B 35.45
Dicerna Pharmaceuticals (DRNA) United States $1.814B 0.00
Denali Therapeutics (DNLI) United States $1.746B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.667B 0.00
Akcea Therapeutics (AKCA) United States $1.654B 0.00
Zymeworks (ZYME) Canada $1.651B 0.00
REGENXBIO (RGNX) United States $1.602B 0.00
Editas Medicine (EDIT) United States $1.559B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.465B 0.00
Epizyme (EPZM) United States $1.393B 0.00
Sangamo Therapeutics (SGMO) United States $1.344B 0.00
Alector (ALEC) United States $1.336B 0.00
Innoviva (INVA) United States $1.314B 3.87
Arvinas (ARVN) United States $1.274B 0.00
Athenex (ATNX) United States $1.274B 0.00
Coherus BioSciences (CHRS) United States $1.232B 0.00
Principia Biopharma (PRNB) United States $1.193B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.114B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.104B 0.00
Fate Therapeutics (FATE) United States $1.026B 0.00
Zealand Pharma (ZEAL) Denmark $0.988B 0.00
Precision BioSciences (DTIL) United States $0.940B 0.00
Pharming Group (PHGUF) Netherlands $0.926B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.921B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.913B 7.67
Codexis (CDXS) United States $0.896B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.861B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Intellia Therapeutics (NTLA) United States $0.842B 0.00
Vericel (VCEL) United States $0.820B 305.83
MiMedx (MDXG) United States $0.818B 0.00
Anika Therapeutics (ANIK) United States $0.814B 26.41
Twist Bioscience (TWST) United States $0.767B 0.00
Heska (HSKA) United States $0.739B 188.92
Revance Therapeutics (RVNC) United States $0.719B 0.00
DBV Technologies S.A (DBVT) France $0.712B 0.00
ANI Pharmaceuticals (ANIP) United States $0.710B 12.10
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Cara Therapeutics (CARA) United States $0.646B 0.00
UROGEN PHARMA (URGN) United States $0.642B 0.00
Cellectis S.A (CLLS) France $0.618B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.593B 0.00
GENFIT S.A (GNFT) France $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
BioDelivery Sciences (BDSI) United States $0.581B 0.00
Cytokineticsorporated (CYTK) United States $0.580B 0.00
PHARMA MAR SA (PHMMF) Spain $0.564B 0.00
Agenus (AGEN) United States $0.559B 0.00
Retrophin (RTRX) United States $0.555B 0.00
AC Immune SA (ACIU) Switzerland $0.553B 12.80
Intra-Cellular Therapies (ITCI) United States $0.542B 0.00
Sorrento Therapeutics (SRNE) United States $0.536B 0.00
Kadmon Holdings (KDMN) United States $0.530B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
Stemline Therapeutics (STML) United States $0.492B 0.00
Clovis Oncology (CLVS) United States $0.486B 0.00
Dynavax Technologies (DVAX) United States $0.477B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.450B 3.11
Merus (MRUS) Netherlands $0.390B 0.00
AnaptysBio (ANAB) United States $0.386B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.363B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.359B 0.00
Arcus Biosciences (RCUS) United States $0.357B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
PDL BioPharma (PDLI) United States $0.341B 8.54
OSMOTICA PHARM (OSMT) United States $0.339B 0.00
Pfenex (PFNX) United States $0.336B 0.00
Cellular Biomedicine (CBMG) United States $0.336B 0.00
Avid Bioservices (CDMO) United States $0.318B 0.00
Geron (GERN) United States $0.304B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Kamada (KMDA) Israel $0.298B 8.71
Kindred Biosciences (KIN) United States $0.297B 0.00
Puma Biotechnology (PBYI) United States $0.290B 0.00
CytomX Therapeutics (CTMX) United States $0.279B 0.00
Compugen (CGEN) Israel $0.276B 0.00
Albireo Pharma (ALBO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.270B 0.00
Cue Biopharma (CUE) United States $0.261B 0.00
Seres Therapeutics (MCRB) United States $0.258B 0.00
MannKind (MNKD) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.239B 0.00
Scholar Rock Holding (SRRK) United States $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.233B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Senesco Technologies (ELOX) United States $0.229B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.224B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
Spero Therapeutics (SPRO) United States $0.219B 0.00
Theratechnologies (THTX) Canada $0.218B 0.00
Exicure (XCUR) United States $0.216B 0.00
XOMA (XOMA) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Athersys (ATHX) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.197B 0.00
Proteostasis Therapeutics (PTI) United States $0.194B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.189B 0.00
Palatin Technologies (PTN) United States $0.181B 4.95
IVERIC Bio (ISEE) United States $0.179B 0.00
Affimed (AFMD) Germany $0.176B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.170B 0.00
ARAVIVE, INC (ARAV) United States $0.168B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.157B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Cerecor (CERC) United States $0.149B 0.00
Alcobra (ARCT) United States $0.149B 0.00
NantKwest (NK) United States $0.148B 0.00
VBI Vaccines (VBIV) United States $0.144B 0.00
Abeona Therapeutics (ABEO) United States $0.141B 0.00
Five Prime Therapeutics (FPRX) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arsanis (XFOR) United States $0.133B 0.00
TELA Bio (TELA) United States $0.133B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.127B 0.00
Arbutus Biopharma (ABUS) Canada $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
Nicox SA (NICXF) France $0.124B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.123B 0.00
Novavax (NVAX) United States $0.121B 0.00
BioTime (LCTX) United States $0.120B 6.15
Adaptimmune Therapeutics (ADAP) United Kingdom $0.119B 0.00
Celyad SA (CYAD) Belgium $0.119B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.100B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
Emmaus Life Sciences (EMMA) United States $0.096B 0.00
Strongbridge Biopharma (SBBP) United States $0.096B 2.57
Aduro Biotech (ADRO) United States $0.095B 0.00
Verastem (VSTM) United States $0.093B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.084B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
OvaScience (MLND) United States $0.081B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.080B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Trevena (TRVN) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Curis (CRIS) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.061B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.058B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
Protalix BioTherapeutics (PLX) Israel $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
Orgenesis (ORGS) United States $0.042B 2.72
Celldex Therapeutics (CLDX) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Bionano Genomics (BNGO) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.026B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
Advaxis (ADXS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00